Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Director/PDMR Shareholding
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 97,500 ordinary shares of 4 pence each in the Company ("Ordinary Shares") on 29 January 2025, at a price of 3.668 pence each.
A summary of Carolyn Rand's resultant holdings is below:
| Director |
Board Position |
Number of Ordinary Shares acquired |
Total beneficial holding of Ordinary Shares following this acquisition |
|
| Number of Ordinary Shares |
Approximate % of Company's issued share capital |
|||
| Carolyn Rand |
Non-Executive Chair |
97,500 |
97,500 |
0.04% |
Contacts:
| Cambridge Nutritional Sciences plc |
||||
| Carolyn Rand, Non-Executive Chair |
||||
| James Cooper, Interim Chief Executive |
||||
| Cavendish Capital Markets Limited |
Tel: 020 7220 0500 |
|||
| Geoff Nash / Edward Whiley (Corporate Finance) |
||||
| Nigel Birks / Harriet Ward (ECM) |
||||
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
| 1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
| a) |
Name |
Carolyn Rand |
||||
| 2 |
Reason for the notification |
|||||
| a) |
Position/status |
Non-Executive Chair |
||||
| b) |
Initial notification /Amendment |
Initial Notification |
||||
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
| a) |
Name |
Cambridge Nutritional Sciences plc |
||||
| b) |
LEI |
2138007U9P4BTZTYIR92 |
||||
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
| a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 4 pence each ISIN: GB00B1VCP282 |
||||
| b) |
Nature of the transaction |
Ordinary Shares purchased |
||||
| c) |
Price(s) and volume(s) |
|
||||
| d) |
Aggregated information -Aggregated volume - Price |
See above |
||||
| e) |
Date of the transaction |
29.01.2025 |
||||
| f) |
Place of the transaction |
London Stock Exchange |
||||